Literature DB >> 35511282

Physical Frailty is Modifiable in Young Cardiac Rehabilitation Patients.

Jack A Hermsen1, Alexander R Opotowsky1,2, Adam W Powell1,2, Wayne A Mays2, Clifford Chin1,2, Justine D Shertzer2, Matthew J Harmon2, Samuel G Wittekind3,4.   

Abstract

Frailty is a standardized, quantitative metric used to assess multisystem physiologic reserve and vulnerability to poor health outcomes. Cardiac rehabilitation (CR) positively impacts patient outcomes, including frailty, in adult cardiovascular disease (CVD); however, both the frailty paradigm and CR are understudied in pediatric CVD. This retrospective, single-center cohort study aimed to determine baseline composite frailty for pediatric-onset CVD patients and examine its change throughout CR using a proposed frailty assessment tool. Youth with pediatric-onset CVD participating in CR were stratified into five CVD diagnostic groups: post-heart transplant (HTx) (n = 34), post-ventricular assist device (VAD) (n = 12), single ventricle (n = 20) and biventricular (n = 29) congenital heart disease, and cardiomyopathy (n = 25), and frailty was assessed at baseline and every 30 days during CR. Post-HTx and post-VAD groups had significantly higher median frailty scores at baseline (6/10 and 5.75/10, respectively) driven by reduced strength, gait speed, and functional status. All groups except post-VAD displayed a significant absolute reduction in frailty from baseline to 120 days (HTx: - 3.5; VAD: - 3; SV CHD: - 1; BV CHD: - 1; CM: - 1.5), with similar median post-CR scores (1-3/10 in all groups). These improvements did not significantly correlate with number of CR sessions attended. This study established that frailty exhibits discriminatory utility across pediatric-onset CVD groups at baseline and is significantly modifiable over time. Improvements in frailty and other fitness metrics are likely due to a combination of post-operative recovery, post-diagnosis pharmacological and lifestyle changes, and CR. Further study of this frailty tool is needed to explore its prognostic utility.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiac rehabilitation; Cardiomyopathy; Congenital heart disease; Frailty; Heart transplant

Year:  2022        PMID: 35511282     DOI: 10.1007/s00246-022-02917-w

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  28 in total

Review 1.  Frailty in childhood cancer survivors.

Authors:  Kirsten K Ness; Gregory T Armstrong; Mondira Kundu; Carmen L Wilson; Tamara Tchkonia; James L Kirkland
Journal:  Cancer       Date:  2014-12-19       Impact factor: 6.860

2.  The impact of frailty on mortality after heart transplantation.

Authors:  Peter S Macdonald; Natasha Gorrie; Xavier Brennan; Samira R Aili; Ricardo De Silva; Sunita R Jha; Rodrigo Fritis-Lamora; Elyn Montgomery; Kay Wilhelm; Rachel Pierce; Fiona Lam; Bruno Schnegg; Christopher Hayward; Andrew Jabbour; Eugene Kotlyar; Kavitha Muthiah; Anne M Keogh; Emily Granger; Mark Connellan; Alasdair Watson; Arjun Iyer; Paul C Jansz
Journal:  J Heart Lung Transplant       Date:  2020-11-21       Impact factor: 10.247

3.  Identification of Frailty in Chronic Heart Failure.

Authors:  Shirley Sze; Pierpaolo Pellicori; Jufen Zhang; Joan Weston; Andrew L Clark
Journal:  JACC Heart Fail       Date:  2019-02-06       Impact factor: 12.035

4.  Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.

Authors:  María T Vidán; Vendula Blaya-Novakova; Elísabet Sánchez; Javier Ortiz; José A Serra-Rexach; Héctor Bueno
Journal:  Eur J Heart Fail       Date:  2016-04-12       Impact factor: 15.534

5.  Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?

Authors:  Mathew S Maurer; Evelyn Horn; Alex Reyentovich; Victoria Vaughan Dickson; Sean Pinney; Deena Goldwater; Nathan E Goldstein; Omar Jimenez; Sergio Teruya; Jeff Goldsmith; Stephen Helmke; Melana Yuzefpolskaya; Gordon R Reeves
Journal:  J Am Geriatr Soc       Date:  2017-09-21       Impact factor: 5.562

6.  A global clinical measure of fitness and frailty in elderly people.

Authors:  Kenneth Rockwood; Xiaowei Song; Chris MacKnight; Howard Bergman; David B Hogan; Ian McDowell; Arnold Mitnitski
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

Review 7.  Cardiac rehabilitation past, present and future: an overview.

Authors:  Warner M Mampuya
Journal:  Cardiovasc Diagn Ther       Date:  2012-03

8.  A Randomized Trial Comparing Cardiac Rehabilitation to Standard of Care for Adults With Congenital Heart Disease.

Authors:  Alexander R Opotowsky; Jonathan Rhodes; Michael J Landzberg; Ami B Bhatt; Keri M Shafer; Doreen DeFaria Yeh; Scott E Crouter; Ana Ubeda Tikkanen
Journal:  World J Pediatr Congenit Heart Surg       Date:  2018-03

9.  Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation.

Authors:  Sunita R Jha; Malin K Hannu; Phillip J Newton; Kay Wilhelm; Christopher S Hayward; Andrew Jabbour; Eugene Kotlyar; Anne Keogh; Kumud Dhital; Emily Granger; Mark Connellan; Paul Jansz; Phillip M Spratt; Elyn Montgomery; Angela Smith; Michelle Harkess; Peta Tunicliff; Patricia M Davidson; Peter S Macdonald
Journal:  Transplant Direct       Date:  2017-05-30

10.  Translation of the Frailty Paradigm from Older Adults to Children with Cardiac Disease.

Authors:  Chaitanya Panchangam; David A White; Suma Goudar; Brian Birnbaum; Lindsey Malloy-Walton; Jami Gross-Toalson; Kimberly J Reid; Girish Shirali; Anitha Parthiban
Journal:  Pediatr Cardiol       Date:  2020-05-06       Impact factor: 1.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.